(Q38019052)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703523%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Ocular drug delivery system: a reference to natural polymers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703523%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703523%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Priyanka Pahuja

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703523%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Sandeep Arora

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703523%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

16 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703523%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Delivery

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703523%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703523%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

837-861

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703523%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703523%20AND%20SRC:MED&resulttype=core&format=json

Recent perspectives in ocular drug delivery

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Mucosal defense of the outer eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Mechanistic studies on transcorneal permeation of pilocarpine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Biopharmaceutical considerations in topical ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Limits on optimizing ocular drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

A study of the causes of non-compliance by patients prescribed eyedrops

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Changing the composition of buffered eye-drops prevents undesired side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Effects of Drug Vehicles on Ocular Contact Time

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Poly(2-hydroxyethyl methacrylate) film as a drug delivery system for pilocarpine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Gel-forming erodible inserts for ocular controlled delivery of ofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Controlled release polymeric ocular delivery of acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Management of acute glaucoma with pilocarpine-soaked hydrophilic lens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Imprinted soft contact lenses as norfloxacin delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Ocular release of timolol from molecularly imprinted soft contact lenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Improved ocular bioavailability of indomethacin by novel ocular drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Mucoadhesive Microparticles Engineered for Ophthalmic Drug Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Development of a topical niosomal preparation of acetazolamide: preparation and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Niosome-encapsulated gentamicin for ophthalmic controlled delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Characterization and in vivo evaluation of ocular minitablets prepared with different bioadhesive Carbopol-starch components

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Studies on a new device for drug delivery to the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Capacity and tolerance of a new device for ocular drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Iontophoretic application of tobramycin to uninfected and Pseudomonas aeruginosa-infected rabbit corneas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Tobramycin iontophoresis into corneas infected with drug-resistant Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

In-vitro permeation of bevacizumab through human sclera: effect of iontophoresis application

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Transscleral iontophoretic and intravitreal delivery of a macromolecule: study of ocular distribution in vivo and postmortem with MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

In vivo transscleral iontophoresis of amikacin to rabbit eyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Transcleral delivery of triamcinolone acetonide and ranibizumab to retinal tissues using macroesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Chitosan chemistry and pharmaceutical perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

In vitro characterization of chitosan scaffolds: influence of composition and deacetylation degree

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Effects of N-trimethylchitosan on transcellular and paracellular transcorneal drug transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Carbopol/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Design and evaluation of polymeric ocular drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Topical use of coenzyme Q10-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention and anti-cataract effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Preparation of rapamycin-loaded chitosan/PLA nanoparticles for immunosuppression in corneal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Chitosan nanoparticles of 5-fluorouracil for ophthalmic delivery: characterization, in-vitro and in-vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Development and characterization of sponge-like acyclovir ocular minitablets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Pilocarpine-loaded chitosan-PAA nanosuspension for ophthalmic delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Mucoadhesive properties of chitosan-coated ophthalmic lipid emulsion containing indomethacin in tear fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

The role of 1% sodium hyaluronate in treating vitreous incarceration with the neodymium:YAG laser in patients with corneal decompensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Intravitreal hyaluronic acid injection. A long-term clinical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Sodium hyaluronate as an ophthalmic vehicle: some factors governing its effect on the ocular absorption of pilocarpine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Ophthalmic delivery of sparfloxacin from in situ gel formulation for treatment of experimentally induced bacterial keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Effect of sodium hyaluronate (0.1%) on break-up time (NIBUT) in patients with dry eyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Carbomer and sodium hyaluronate eyedrops for moderate dry eye treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Mucoadhesive and penetration enhancement properties of three grades of hyaluronic acid using porcine buccal and vaginal tissue, Caco-2 cell lines, and rat jejunum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Bioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Mucoadhesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin/prednisolone bitherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Ocular hypotensive efficacy and safety of once daily carteolol alginate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Sodium alginate based mucoadhesive system for gatifloxacin and its in vitro antibacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Azithromycin novel drug delivery system for ocular application

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Alginate microsphere-collagen composite hydrogel for ocular drug delivery and implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

A long acting ophthalmic gel formulations of atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Environmentally responsive ophthalmic gel formulation of carteolol hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

L-Carnosine: multifunctional dipeptide buffer for sustained-duration topical ophthalmic formulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

In situ gelling gelrite/alginate formulations as vehicles for ophthalmic drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Gellan-based scleral implants of indomethacin: in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

In vitro evaluation of in situ gels as short term vitreous substitutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

21 January 2018

Collagen corneal shields

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Collagen shield heparin delivery for prevention of postoperative fibrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Ocular inserts for application of drugs to bovine eyes--in vitro studies on gentamicin release from collagen inserts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochloride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Formulation and evaluation of ciprofloxacin hydrochloride soluble ocular drug insert

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Development of polyvinyl alcohol-gelatin membranes for antibiotic delivery in the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Ophthalmic delivery systems based on drug-polymer-polymer ionic ternary interaction: in vitro and in vivo characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Albumin as a tear supplement in the treatment of severe dry eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Albumin microspheres as an ocular delivery system for pilocarpine nitrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Long-term intraocular pressure-lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with Timoptic XE 0.5% in a 12-month study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Carrageenan-gelatin mucoadhesive systems for ion-exchange based ophthalmic delivery: in vitro and preliminary in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Effects of lambda-carrageenan on in vitro replication of feline herpesvirus and on experimentally induced herpetic conjunctivitis in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Effect of different sterilisation methods on the properties of bioadhesive powders and ocular minitablets, and clinical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Ocular bioerodible minitablets as strategy for the management of microbial keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

In vitro evaluation of gentamicin- and vancomycin-containing minitablets as a replacement for fortified eye drops

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Characterization and intermolecular interactions of hydroxypropyl guar solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Pre-clinical investigation of the efficacy of an artificial tear solution containing hydroxypropyl-guar as a gelling agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

A nuclear magnetic resonance approach to the comparison of mucoadhesive properties of polysaccharides for ophthalmic uses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

A mucoadhesive polymer extracted from tamarind seed improves the intraocular penetration and efficacy of rufloxacin in topical treatment of experimental bacterial keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Synergistic interaction between TS-polysaccharide and hyaluronic acid: implications in the formulation of eye drops

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Selected polysaccharides at comparison for their mucoadhesiveness and effect on precorneal residence of different drugs in the rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Larch arabinogalactan for hepatic drug delivery: isolation and characterization of a 9 kDa arabinogalactan fragment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Arabinogalactan as active compound in the management of corneal wounds: in vitro toxicity and in vivo investigations on rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Gum cordia: a novel matrix forming material for enteric resistant and sustained drug delivery--a technical note.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Preparation and evaluation of nanoparticles of gum cordia, an anionic polysaccharide for ophthalmic delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

A polysaccharide isolated from the medicinal herb Bletilla striata induces endothelial cells proliferation and vascular endothelial growth factor expression in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Novel mucoadhesive polysaccharide isolated from Bletilla striata improves the intraocular penetration and efficacy of levofloxacin in the topical treatment of experimental bacterial keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Larch Arabinogalactan for Dry Eye Protection and Treatment of Corneal Lesions: Investigations in Rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

Microspheres and nanoparticles used in ocular delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2012.690733

10.1517/17425247.2012.690733

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703523%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference